ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients

Society for Melanoma Research Abstracts Published Online in Organization’s JournalContinue reading

Dr. Robert Penny Honored by College of American Pathologists

The College of American Pathologists recently awarded Dr. Robert Penny the 2012 Distinguished Patient Care Award at its annual meeting.  Dr. Penny was recognized for his extensive scientific translational research to accelerate the adoption of molecular pathways and associated therapies into the field of pathology and oncology to improve the lives of cancer patients.Continue reading

Ulthera Announces Issuance of Patent for New Medical Field of Use

Ulthera, Inc. – a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – announces the issuance of U.S. Patent No. 8,282,554 this week from the U.S. Patent and Trademark Office (USPTO). The patent, titled “Methods for Treatment of Sweat Glands” relates to the therapeutic use of energy for the treatment of conditions resulting from sweat gland disorders, such as hyperhidrosis.Continue reading

Ulthera Receives First-Ever FDA Clearance for Non-invasive Lift of Skin on the Neck and Under the Chin

Ulthera, Inc. – a global, high-growth medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced that its ultrasound platform device, the Ulthera System, has received FDA clearance to non-invasively lift lax tissue on the neck and the submental (under the chin). Continue reading